Results 91 to 96 of about 54,214 (96)

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Investigational new drugs, 2005
Susan M. Chang, P. Wen, T. Cloughesy, H. Greenberg, D. Schiff, C. Conrad, K. Fink, H. Robins, L. Angelis, J. Raizer, K. Hess, K. Aldape, K. Lamborn, J. Kuhn, J. Dancey, M. Prados, North American Brain Tumor Consortium and the National C Institute   +16 more
semanticscholar   +1 more source

Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma (RCC): Safety and activity in RTKI refractory RCC patients.

Journal of Clinical Oncology, 2009
J. Merchan, H. Pitot, R. Qin, G. Liu, T. Fitch, J. Picus, W. Maples, C. Erlichman   +7 more
semanticscholar   +1 more source

A Phase 1 clinical study of temsirolimus (CCI-779) in Japanese patients with advanced solid tumors.

Japanese Journal of Clinical Oncology, 2010
Y. Fujisaka, Y. Yamada, N. Yamamoto, A. Horiike, T. Tamura   +4 more
semanticscholar   +1 more source

The effect of urgent-start peritoneal dialysis and urgent-start hemodialysis on clinical outcomes in patients with chronic kidney disease: an updated systematic review and meta-analysis.

International Urology and Nephrology
Peixin Duan, Hailuo Zhang, Yun Zhang
semanticscholar   +1 more source

Multicenter Study of Ultrasound Real-Time Tissue Elastography in 779 Cases for the Assessment of Breast Lesions: Improved Diagnostic Performance by Combining the BI-RADS®-US Classification System with Sonoelastography

Ultraschall in der Medizin, 2010
S. Wojcinski, A. Farrokh, Stefan Weber, Anke Thomas, T. Fischer, T. Slowinski, W. Schmidt, F. Degenhardt   +7 more
semanticscholar   +1 more source

Relationships between Providers and Users of Market Research: The Dynamics of Trust within and between Organizations

, 1992
C. Moorman, G. Zaltman, Rohit Deshpandé
semanticscholar   +1 more source